Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/18/2026 | Q4 | $469.6M | -- | -- | $0.09 | -- |
| 11/05/2025 | Q3 | $513M | $513.7M | -$0.06 | $0.31 | -$0.37 |
| 08/06/2025 | Q2 | $505.5M | $525.4M | -$0.18 | $0.20 | -$0.38 |
| 05/07/2025 | Q1 | $470.3M | $484.8M | -$7.82 | -$0.11 | -$7.71 |
| 02/19/2025 | Q4 | $472.7M | $458.6M | $0.03 | $0.02 | $0.01 |
| 11/06/2024 | Q3 | $524.4M | $498.5M | -$0.38 | $0.28 | -$0.66 |
| 08/07/2024 | Q2 | $525.8M | $523.8M | -$0.03 | $0.23 | -$0.26 |
| 05/08/2024 | Q1 | $489.6M | $500.2M | -$0.52 | $0.20 | -$0.71 |
| 02/21/2024 | Q4 | $461.1M | $452.3M | -$0.23 | $0.14 | -$0.36 |
| 11/08/2023 | Q3 | $545.1M | $503.3M | -$8.33 | $0.09 | -$8.42 |
| 08/09/2023 | Q2 | -- | $526.5M | -$0.08 | -- | -- |
| 05/10/2023 | Q1 | -- | $549M | -$0.14 | -- | -- |
| 02/22/2023 | Q4 | -- | $524.4M | $0.04 | -- | -- |
| 11/09/2022 | Q3 | -- | $551.2M | -$0.43 | -- | -- |
| 08/09/2022 | Q2 | -- | $426.4M | $0.38 | -- | -- |
| 05/04/2022 | Q1 | -- | $406.8M | $0.04 | -- | -- |
| 12/31/2021 | Q4 | -- | $390.8M | $1.68 | -- | -- |
| 09/30/2021 | Q3 | -- | $383.9M | $0.38 | -- | -- |
| 06/30/2021 | Q2 | -- | $378.2M | $0.05 | -- | -- |
| 03/31/2021 | Q1 | -- | $288.8M | $0.68 | -- | -- |
| 12/31/2020 | Q4 | -- | $280.3M | $0.48 | -- | -- |
| 09/30/2020 | Q3 | -- | $280.2M | $0.78 | -- | -- |
| 06/30/2020 | Q2 | -- | $255.2M | $0.68 | -- | -- |
| 03/31/2020 | Q1 | -- | $262.1M | $0.72 | -- | -- |
| 12/31/2019 | Q4 | -- | $236.4M | $0.65 | -- | -- |
| 09/30/2019 | Q3 | -- | $256.7M | $0.90 | -- | -- |
| 06/30/2019 | Q2 | -- | $270.3M | $0.66 | -- | -- |
| 03/31/2019 | Q1 | -- | $258.2M | $0.56 | -- | -- |
| 12/31/2018 | Q4 | -- | $248.5M | $0.23 | -- | -- |
| 09/30/2018 | Q3 | -- | $260.4M | $1.32 | -- | -- |
| 06/30/2018 | Q2 | -- | $270.3M | $0.83 | -- | -- |
| 03/31/2018 | Q1 | -- | $261.3M | $0.67 | -- | -- |
| 12/31/2017 | Q4 | -- | $235.4M | -$0.89 | -- | -- |
| 09/30/2017 | Q3 | -- | $257.6M | $0.84 | -- | -- |
| 06/30/2017 | Q2 | -- | $255.4M | $0.72 | -- | -- |
| 03/31/2017 | Q1 | -- | $233.3M | $0.45 | -- | -- |
| 12/31/2016 | Q4 | -- | $198.7M | $0.55 | -- | -- |
| 09/30/2016 | Q3 | -- | $209.7M | $0.61 | -- | -- |
| 06/30/2016 | Q2 | -- | $220.8M | $0.85 | -- | -- |
| 03/31/2016 | Q1 | -- | $216.4M | $0.69 | -- | -- |
| 12/31/2015 | Q4 | -- | $209.8M | $0.71 | -- | -- |
Mativ Holdings, Inc. reported $513.7M worth of top line sales in its most recent quarter.
Mativ Holdings, Inc. announced earnings per share of -$0.06 which represents a miss of analyst forecast a $0.31 per share.
Mativ Holdings, Inc. reported $83.4M that represents $1.53 per share over the last quarter.
Mativ Holdings, Inc.'s earnings are forecast to grow from -$0.90 per share to $0.59 per share next year representing an increase of --.
Mativ Holdings, Inc.'s next earnings date is February 18, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.